Description
API Pharmaceutical CAS 51-43-4 Epinephrine Powder With 99% Min Purity
Description
Product Name: | Renostyptin | Other Name: | Epinephrine |
---|---|---|---|
CAS No: | 51-43-4 | MF: | C9H13NO3 |
MW: | 183.2 | Purity: | 99% Min |
Shelf Life: | 2 Years | Application: | First Aid Medicine To Restore Heart Function |
Sample: | Available | Storage: | Cool And Dry Place |
High Light: |
Pharmaceutical Epinephrine Powder, 99% Min Purity Epinephrine Powder, API Powder CAS 51-43-4 |
Pharmaceutical API High Purity Amino Acid Medical Raw CAS 51-43-4 Epinephrine
Product Introduction
Name: L(-)-Epinephrine
English synonym: Renostyptin
CAS Number: 51-43-4
Molecular formula: C9H13NO3
Molecular mass: 183.2
EINECS number: 200-098-7
Product Description
Melting point: 215°C(dec.)(lit.)
Specific rotation: -51.5º(c=4,1MHCl,drysub)
Boiling point: 316.88°C(rough estimate)
Density: 1.1967(rough estimate)
Refractive index: -51.5°(C=4,1mol/LHCl)
Storage conditions: 2-8°C
Solubility: Practically insoluble in water, in ethanol (96percent) and in methylene chloride. It dissolves in hydrochloric acid.
Form: Fine Crystalline Powder
Acidity coefficient (pKa): 8.66(at25℃)
Color: White to light beige
Water solubility: <0.01g/100mL at 18ºC Decomposition>212°C
Sensitivity: Air&Light Sensitive
Stability: Stable. Incompatible with acids, acid chlorides, acid anhydrides, oxidizing agents. Light sensitive.
Product Function
1. As a first aid medicine for restoring heart function: often used for weak heartbeats or sudden arrests caused by anaphylactic shock, drowning, infectious diseases, drug poisoning, surgical accidents, and heart block. When the heartbeat stops completely, intracardiac injection can be used, combined with effective artificial respiration, heart massage and other measures.
2. For allergic diseases: subcutaneous or intramuscular injection can treat allergic diseases, such as anaphylactic shock, urticaria, bronchial asthma, laminitis, etc. It is also effective for allergic reactions caused by immune serum and vaccines.
3. Compatible with local anesthetics: add 0.5-1ml of 0.1% epinephrine solution to every 100ml of local anesthetics to constrict local blood vessels, delay the absorption of local anesthetics, prolong the anesthesia time and reduce the toxicity of the anesthetics.
4. External use as a local hemostatic agent: a 1:5000-1:100,000 solution for topical application can constrict local blood vessels and prevent bleeding in the nasal mucosa, uterus, gums or surgical sites.